Multiple guidelines indicate that high-risk individuals and families benefit from precise risk stratification, including BRCA1/2 carriers initiating breast MRI screening at age 25, and prophylactic salpingo-oophorectomy reduces ovarian cancer mortality in BRCA+ individuals [72]. This evidence concerns the gene BRCA1 and ovarian carcinoma.